For instance, the pan-caspase inhibitor quinoline-Val-Asp-difluorophenoxymethylketone (qVD-OPh) is reported to inhibit COPD in MLKL knockdown mice [119]. Here, MLKL is linked to chronic obstructive pulmonary disease.